Interacted genes from RAID,miRTarBase |
CASP8,FGFR2,CCND1,ITGB8,BCL2L11,HIF1A,DNAH8,KDR
more »
CASP8,FGFR2,CCND1,ITGB8,BCL2L11,HIF1A,DNAH8,KDR
|
|
KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
hsa05200
|
Pathways in cancer |
CCND1,CASP8,HIF1A,FGFR2, |
2.41E-2 |
hsa04510
|
Focal adhesion |
CCND1,ITGB8,KDR, |
1.43E-1 |
hsa04115
|
p53 signaling pathway |
CCND1,CASP8, |
6.51E-1 |
hsa05416
|
Viral myocarditis |
CCND1,CASP8, |
6.79E-1 |
hsa05215
|
Prostate cancer |
CCND1,FGFR2, |
8.45E-1 |
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0008284
|
positive regulation of cell proliferation |
CCND1,HIF1A,FGFR2,KDR, |
9.08E-4 |
GO:0008406
|
gonad development |
CCND1,KDR,BCL2L11, |
1.38E-2 |
GO:0048608
|
reproductive structure development |
CCND1,KDR,BCL2L11, |
1.75E-2 |
GO:0035239
|
tube morphogenesis |
CASP8,KDR,BCL2L11, |
1.78E-2 |
GO:0045137
|
development of primary sexual characteristics |
CCND1,KDR,BCL2L11, |
1.78E-2 |
|
GO:0001525
|
angiogenesis |
CASP8,HIF1A,KDR, |
2.40E-2 |
GO:0007548
|
sex differentiation |
CCND1,KDR,BCL2L11, |
2.50E-2 |
GO:0048514
|
blood vessel morphogenesis |
CASP8,HIF1A,KDR, |
4.82E-2 |
GO:0035295
|
tube development |
CASP8,KDR,BCL2L11, |
5.23E-2 |
GO:0042127
|
regulation of cell proliferation |
CCND1,HIF1A,FGFR2,KDR, |
5.75E-2 |
GO:0001568
|
blood vessel development |
CASP8,HIF1A,KDR, |
6.46E-2 |
GO:0001944
|
vasculature development |
CASP8,HIF1A,KDR, |
6.77E-2 |
GO:0048534
|
hemopoietic or lymphoid organ development |
CASP8,KDR,BCL2L11, |
7.25E-2 |
GO:0003006
|
reproductive developmental process |
CCND1,KDR,BCL2L11, |
7.35E-2 |
GO:0002520
|
immune system development |
CASP8,KDR,BCL2L11, |
8.13E-2 |
GO:0048870
|
cell motility |
HIF1A,KDR,DNAH8, |
9.99E-2 |
GO:0051674
|
localization of cell |
HIF1A,KDR,DNAH8, |
9.99E-2 |
|
|
|
|
|
|